Haig P. Bozigian
2016
In 2016, Haig P. Bozigian earned a total compensation of $2.7M as Chief Development Officer at Neurocrine Biosciences, a 15% increase compared to previous year.
Compensation breakdown
| Bonus | $197,500 |
|---|---|
| Option Awards | $979,215 |
| Salary | $395,000 |
| Stock Awards | $1,104,893 |
| Other | $40,278 |
| Total | $2,716,886 |
Bozigian received $1.1M in stock awards, accounting for 41% of the total pay in 2016.
Bozigian also received $197.5K in bonus, $979.2K in option awards, $395K in salary and $40.3K in other compensation.
Rankings
In 2016, Haig P. Bozigian's compensation ranked 3,583rd out of 14,075 executives tracked by ExecPay. In other words, Bozigian earned more than 74.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,583 out of 14,075 | 75th |
Division Manufacturing | 1,249 out of 5,489 | 77th |
Major group Chemicals And Allied Products | 381 out of 1,895 | 80th |
Industry group Drugs | 278 out of 1,538 | 82nd |
Industry Biological Products, Except Diagnostic Substances | 55 out of 279 | 80th |
Source: SEC filing on April 20, 2017.
Bozigian's colleagues
We found five more compensation records of executives who worked with Haig P. Bozigian at Neurocrine Biosciences in 2016.
2016
Kevin Gorman
Neurocrine Biosciences
Chief Executive Officer
2016
Timothy Coughlin
Neurocrine Biosciences
Chief Financial Officer
2016
Christopher O'Brien
Neurocrine Biosciences
Chief Medical Officer
2016
Eric Benevich
Neurocrine Biosciences
Chief Commercial Officer
2016
Kyle Gano
Neurocrine Biosciences